Figure 3 : Macular OCT (Zeiss) images before and after intravitreal
injection of aflibercept.

(A) Recurrent CME with intraretinal fluid in the fovea, BCVA 20/80,
CFT 785 μm/14.4 mm2. (B) Clinical improvement three weeks after
administration of intravitreal aflibercept with BCVA 20/50,
CFT 319 μm/9.2 mm2.

Todorich et al.Journal of Eye and Ophthalmology  2014 1:3DOI : 10.7243/2055-2408-1-3